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Members of the bone morphogenetic protein family of secreted protein signals have been implicated as axon guidance cues
for specific neurons in Caenorhabditis elegans and in mammals. We have examined axonal pathfinding in mice lacking the
secreted bone morphogenetic protein antagonist Noggin. We have found defects in projection of several groups of neurons,
including the initial ascending projections from the dorsal root ganglia, motor axons innervating the distal forelimb, and
cranial nerve VII. The case of the dorsal root ganglion defect is especially interesting: initial projections from the dorsal root
ganglion enter the dorsal root entry zone, as normal, but then project directly into the gray matter of the spinal cord, rather
than turning rostrally and caudally. Explant experiments suggest that the defect lies within the spinal cord and not the
dorsal root ganglion itself. However, exogenous bone morphogenetic proteins are unable to attract or repel these axons, and
the spinal cord shows only very subtle alterations in dorsal–ventral pattern in Noggin mutants. We suggest that the defect
in projection into the spinal cord is likely the result of bone morphogenetic proteins disrupting the transduction of some
unidentified repulsive signal from the spinal cord gray matter. © 2002 Elsevier Science (USA)
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The mammalian nervous system exhibits a tremendously
complex and highly conserved pattern of connectivity.
During development, many neurons project axons simulta-
neously, to many different targets: if axons are to be guided
by target- and pathway-derived factors, then many different
factors must be present, and different kinds of neurons
must be responsive to different factors. In keeping with this
apparent complexity, a large number of factors have been
implicated as axon-guidance cues in recent years, including
Ephrins, Semaphorins, Slits, and Netrins (Mueller, 1999).
Generally speaking, these signals act by inducing local
changes in the actin cytoskeleton, resulting in local actin
polymerization and cytoskeletal protrusions toward
sources of attractants, and local actin depolymerization
followed by protrusions falling back from sources of repel-
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All rights reserved.lents (Mueller, 1999). Different neurons respond differently
to different cues, even cues within the same family (e.g., de
Castro et al., 1999).
One group of proteins which has received attention
recently as potential axon guidance cues is the bone mor-
phogenetic proteins (BMPs). BMPs were first isolated bio-
chemically as activities that could induce ectopic bone
formation in rat soft tissues (Wang et al., 1988). When the
active proteins were purified and sequenced, and the genes
encoding them cloned, they were found to be homologous
to the Drosophila gene decapentaplegic (dpp), a member of
the transforming growth factor  (TGF) superfamily of
secreted signals (Gelbart, 1989; Wozney et al., 1988). The
Drosophila BMP family members dpp, screw, and glass-
bottomed boat/60A play roles in a wide variety of develop-
mental processes, including the establishment of initial
dorsal–ventral polarity in the Drosophila ectoderm and
development of various imaginal disc-derived structures
(Gelbart, 1989). This family of proteins has undergone
dramatic evolutionary expansion: vertebrate genomes con-
tain 20 or more BMPs (Neuhaus et al., 1999). Loss-of-
function mutants in the vertebrate BMPs display a tremen-
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dous variety of defects, and BMP overexpression can cause
a wide variety of developmental defects (Hogan, 1996).
In addition to their many activities in cell-type specifica-
tion, BMPs have also been implicated as regulators of
axonal growth. In Caenorhabditis elegans, the BMP family
member unc-129 is involved in proper guidance of motor
axons (Colavita et al., 1998). In the rat, BMP7 is a chemore-
pellent for dorsal commissural axons (Augsburger et al.,
1999). Other TGF superfamily members are also able to
signal to the cytoskeleton: most notably, TGF1 itself is a
homing factor for many immune cell types (Adams et al.,
1991; Brandes et al., 1991). The mechanism by which TGF
superfamily members modulate the cytoskeleton remains
to be elucidated.
It is possible that axon guidance may be regulated not
only by BMPs, but also, indirectly, by their antagonists.
Work on the BMP antagonist DAN brought this issue into
focus because Dan mRNA is selectively localized to pro-
jecting axons, where we concluded it might play some role
in axon guidance (Dionne et al., 2001). Although we were
unable to find any guidance defects in Dan mutants, we
also examined Noggin mutants and Dan/Noggin compound
mutants for defects in axon guidance. Here, we describe
defects found in Noggin mutant mice. Noggin was origi-
nally isolated in an overexpression screen for proteins able
to induce dorsal cell fates in the early Xenopus embryo
(Smith and Harland, 1992). Noggin encodes a secreted
protein which binds to BMP family members and prevents
them from activating their receptors (Zimmerman et al.,
1996). Mice lacking Noggin have previously been exten-
sively characterized with regard to defects in somite and
neural fates and skeletal pattern (Brunet et al., 1998; Mc-
Mahon et al., 1998). Noggin mice had not been examined
for defects in neural connectivity. We reasoned that the loss
of Noggin activity might result in axonal misguidance due
to excessive BMP signals, either directly (with BMPs acting
as guidance cues) or indirectly (with BMPs disrupting other
guidance cues).
MATERIALS AND METHODS
Mice
The Noggin mutant mice used were those previously described
(McMahon et al., 1998). Genotyping was done by PCR, as previ-
ously described (McMahon et al., 1998). The Noggin animals were
at least eight generations backcrossed onto a C57Bl6/J background.
Immunofluorescence
Immunofluorescence was carried out as previously described
(Dionne et al., 2001). Primary antibodies used included purified
rabbit polyclonal anti-MATH1 (Helms and Johnson, 1998), used at
1:200, a gift of J. Johnson; mouse monoclonal anti-MASH1 (Lo et
al., 1991), used as an unpurified supernatant at 1:1, a gift of D.
Anderson; purified rabbit polyclonal anti-Ephrin-B (C-18) (Santa
Cruz), used at 1:100; mouse monoclonal anti-Pax7 and anti-Pax6,
used as unpurified supernatants at 1:1 (Developmental Studies
Hybridoma Bank); polyclonal rabbit anti--galactosidase (533),
used at 1:200; and mouse monoclonal anti-neurofilament 2H3
(Developmental Studies Hybridoma Bank), used as an unpurified
supernatant at 1:50. Secondary antibodies used included Texas Red
goat anti-rabbit IgG, FITC goat anti-mouse IgG, and Rhodamine
Red X goat anti-mouse IgG; all were purchased from Jackson
ImmunoResearch.
DiI Labeling
Mouse embryos were fixed for at least 12 h, and as long as several
weeks, in 4% formaldehyde in PBS at 4°C. Small crystals of DiI
(Molecular Probes) were implanted by using glass needles. The DiI
was allowed to diffuse for 3 days at room temperature in the dark
in 4% formaldehyde/PBS. The embryos were then embedded in 5%
low-melt agarose in PBS and sectioned at 100 m on a vibratome.
Sections were collected on Superfrost Plus slides (Fisher), mounted
with Vectashield (Vector Research), and immediately examined
and photographed.
Cell Culture Methods
Dorsal root ganglia were dissected from e11.5 mouse embryos
and cultured as previously described (Keynes et al., 1997), with the
following modifications: LIF was added as an unpurified COS
supernatant, at a concentration which we had previously deter-
mined as sufficient to maintain ES cells in an undifferentiated
state; cultures were set up in individual wells of 6- or 12-well tissue
culture plates. NGF 7S and ITS-G were purchased from Gibco,
BDNF and NT-3 were gifts of Regeneron Pharmaceuticals, and Rat
Tail Collagen I was purchased from Collaborative Research/Becton
Dickinson.
COS-7 or HEK293 cell pellets were produced as previously
described (Shah et al., 1997), with the following modifications:
cells were transfected by using Lipofectamine Plus (Gibco) follow-
ing the manufacturer’s instructions; after transfection, cells were
cultured in OptiMEM (Gibco) with 4% fetal bovine serum. The
following plasmids were used for transfection and expression:
Xenopus noggin, A3.pMT21 (Smith et al., 1993); Xenopus BMP4,
pCDM8-XBMP (Nishimatsu et al., 1992), a gift of A. Suzuki;
Xenopus OP1/BMP7, pcDNAIII-XOP-1H (Wang et al., 1997), a gift
of M. Moos; mouse GDF7, BMP4-GDF7/pMT23 (Lee et al., 1998),
a gift of T. Jessell. Mouse BMP2, BMP4, BMP7, and eGFP were
expressed from plasmids based on pCS2 (Rupp et al., 1994; Turner
and Weintraub, 1994). In cases where heterodimer formation was
not expected or required, cells were transfected separately for each
plasmid and then mixed to make pellets which expressed both
proteins. eGFP was used to monitor transfection efficiency and
eGFP-transfected cells were used to make control cell pellets. We
confirmed that BMP4 and GDF7 proteins were present in the
supernatants of transfected HEK293 cells by Western blot analysis.
Proteins were initially concentrated from 1 to 2 ml of supernatant
using either Centricon YM-10 Centrifugal Filter Devices (Millipore
Corporation) or by immunoprecipitation using Fc-tagged human
noggin (Zimmerman et al., 1996) crosslinked to Protein A Sepha-
rose (Pharmacia Biotech; Harlow and Lane, 1988). Immunoblotting
was carried out after separation of proteins by SDS–PAGE and
transfer to nitrocellulose membrane (Schleicher & Schuell, NH).
Blots were probed with Fc-tagged noggin to detect BMP/GDF and
with a POD-labeled anti-human secondary antibody (Promega);
bound antibodies were detected by BM Chemiluminescence
(Boehringer Mannheim).
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Once the cultures had grown for 24 h at 37° with 5% CO2, they
were fixed for 1–2 h in 4% paraformaldehyde in PBS at room
temperature. In situations requiring consistent visualization of
axons deep in the embedded tissues, Dent’s fixative (80% metha-
nol, 20% DMSO) was used instead of paraformaldehyde. After
fixation, each collagen lump was carefully peeled away from the
dish and placed in PBS for immunostaining.
In Situ Hybridization
Probes were prepared and in situ hybridization was carried out as
previously described (Dionne et al., 2001).
Immunostaining of Whole Embryos and Collagen
Gel Cultures
Embryos were fixed for 1–2 h at room temperature in Dent’s
fixative (4:1 methanol:DMSO), rinsed once in 80% methanol, and
bleached by incubation for 4–6 h in 80% methanol, 6% H2O2.
Embryos were then either passed into 100% methanol (for long-
term storage at 20°C) or rehydrated through a methanol series,
culminating in a PBS rinse. Embryos were then blocked in PBS with
1% heat-inactivated goat serum, 2% BSA, and 0.1% Triton X-100
(PHBT) for 1 h at room temperature. The blocking solution was
then replaced with PHBT  antibody and incubated for 4 h at room
temperature. The anti-neurofilament antibody 2H3 (Developmen-
tal Studies Hybridoma Bank) was applied at 1:50 as an unpurified
supernatant. Tissues were then washed at least five times in PHBT,
for at least 1 h each at room temperature. Next, tissues were
incubated for 4 h at room temperature in PHBT 1% HRP-coupled
goat anti-mouse IgG (Pharmingen) and then washed as before.
Embryos were then transferred to PBS 0.5 mg/ml DAB, incubated
for 1 h at 4°C, and then 0.5 l 30% H2O2 was added for each ml
PBS/DAB. Staining was allowed to proceed until visible, and then
DAB was washed out with PBS, and embryos were mounted in 80%
glycerol or 2:1 benzyl benzoate:benzyl alcohol for photography.
Collagen cultures were stained similarly, except that they were
fixed in 4% paraformaldehyde and were not bleached.
RT-PCR
RT-PCR was performed largely as described previously (Wilson
and Melton, 1994), with the exception that the quantity of DNAse
I was doubled, and the reaction time was also doubled, since the
mouse tissue samples contained much more genomic DNA than
comparably sized Xenopus samples. Primers used were: Sema3A,
gtg gaa cac gga ttc atg c, ttt gtc ggc gtt gct ttc g; Sema3B, agg cgc atg
tgc agt gga c, cac caa ctg cag aaa gtc c; Sema3C, aac cca ctg aca caa
tgc c, ggc tat ggt ctg ttt gaa gc; Sema3E, ttg gag gtg gtc gaa gag c, agt
gct cag ctt tag agc g; Sema3F, aga tgt ccg tca cgg gaa c, tgc tct gta cgc
agg aag c; Sema4A, ctc cta ttg ggt aga cag c, gtt gtt gtc ggc atc tac g;
Sema4B, ctt tct cta ccg aca tcg g, gga gac acc tct aca aag c; Sema4C,
aga gct aga aaa ggg tgc c, tcg taa ttc atc cgc gag c; Sema4D, aac tgc
tac aag ggc tac c, cgt cag cat ccg aat ctg c; Sema4F, ctg gtt ggc ttt ttc
ctg g, ata gac gtc tca tcg cac g; Sema4G, tga tgg aga agg aac tgg g, aca
agc tgt gtg tgc ttc c; Sema5A, atc tgt ggc aag atc cag c, gcg ttg gaa tag
gtc ttc c; Sema5B, tgt cat cct acc tgc ttc c, cag ctg ttg ggg aaa cag c;
Sema6A, tgc agg aga aac gga aac c, aca tag ggt gaa ctc tcg c; Sema6B,
ttc ttg tga agc cca acg c, cat ctt gct caa acg tgg c; Sema6C, tcc cga
tcc att ccc atc c, cag gaa ggt agt gta gag c; Sema7A, cca ttg cag aag
gtt tcc c, gac caa gta tga gtg tgg g; EphB2, aac tgt gta tgc cgc aac, ggt
cac tga tgt aga tgc; EphB3, tcc tgg gag tta caa agc, act cta cgt tgt cat
cgc; EphB4, agt tca cct tgc act acc, aag cag caa cct caa agg; Ornithine
Decarboxylase, tca ctc cct ttt acg cag, tgc tgg ttt tga gtg tgg.
RESULTS
Gross Defects in Axon Guidance in Noggin-Mutant
Mice
Because BMP-7 acts as a guidance cue for spinal cord
commissural axons (Augsburger et al., 1999), we examined
axonal projections in mice lacking the secreted BMP antag-
onist Noggin, reasoning that these animals might display
defects in the guidance of other BMP-responsive axonal
populations (McMahon et al., 1998). Defects were apparent
even at the superficial level in a variety of populations (Fig.
1). All defects discussed were present at 100% penetrance in
at least five animals, except as mentioned.
One defect which was immediately apparent was in the
projection of motor axons into the most distal portions of
the ventral forelimb (Figs. 1A and 1B). In wild-type fore-
limbs at e13.5, these axons project to the bases of the
interdigital spaces and bifurcate, sending fascicles along the
edges of each of the digits (Fig. 1A). In contrast, in Noggin
mutants, these fascicles fail to bifurcate and project directly
into the interdigital space (Fig. 1B).
A second defect in the Noggin mutant is apparent at e11.5
in the projection of cranial nerve VII into the muscles of the
face (Figs. 1C and 1D). In wild-type animals, cranial nerve
VII sends a projection deep and rostral to innervate the
muscles of the face (arrowhead in Fig. 1C). This projection
is present in Noggin mutants but projects too far toward the
midline (arrowhead in Fig. 1D) and bifurcates to send a
projection across the midline (arrow in Fig. 1D).
Finally, Noggin mutants displayed aberrant mixing of
projections from the dorsal root ganglia (Figs. 1E and 1F).
This defect was severe enough that it was difficult to
physically separate the dorsal root ganglia for explants. This
defect was seen in all Noggin animals examined. The
severity of this defect and the general increase in axonal
staining in the spinal cord inspired us to look more closely
at pathfinding by DRG axons in animals carrying only the
Noggin mutation.
Defects in DRG Axon Pathfinding
When Noggin mutant embryos were examined in trans-
verse section at the forelimb level, it became clear that
DRG axon pathfinding was severely perturbed in these
animals (Fig. 2). We restricted our analysis to the forelimb
level because the posterior spinal cord is morphologically
disrupted and severely mispatterned (McMahon et al., 1998;
and data not shown). At e11.5 in wild-type animals, the
dorsal root ganglia have projected into the dorsal root entry
zone (DREZ) of the spinal cord (arrowhead in Figs. 2A, 2B,
2D, and 2E). Once in the DREZ, the axons bifurcate and
send projections rostrally and caudally along the length of
the spinal cord (Ozaki and Snider, 1997). In Noggin mu-
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FIG. 2. Closer analysis of defects in projections from the dorsal root ganglion; Noggin expression in dorsal spinal cord. (A, B, D) Sections
through the spinal cord at forelimb level, stained with 2H3. In wild-type animals (A), few or no axons emerge from the DREZ (indicated
by the arrowhead); in contrast, in Noggin mutant embryos (B, D), there are many projections from the DREZ into the deep zone of the spinal
cord. In (D), medial is to the left, lateral to the right. (C) -Galactosidase (blue) and 2H3 (red) expression in the spinal cord and DRG at e11.5.
Sections were taken and processed as above. (E) DiI tracing of projections to the forelimb in a Noggin mutant, demonstrating that the
ectopic projections in the spinal cord are derived from the DREZ and hence presumably from the DRG. The DREZ is again indicated by
the arrowhead. Medial is to the left, lateral to the right.
FIG. 3. Noggin is required in the spinal cord, not the dorsal root ganglion, for proper guidance of DRG axons. Explant cultures in which
mutant or wild-type dorsal root ganglia have been apposed to mutant or wild-type spinal cords were cultured for 24 h, and then sectioned
and stained with 2H3 (green) and with Hoechst dye (blue; to indicate the location of living tissues). In each picture, the ectopic dorsal root
ganglion is separated from the spinal cord by a white dotted line. The ectopic dorsal root ganglion was identified before sectioning in each
case by examination of the explant; the explanted pieces of spinal cord adopted a stereotypical shape, which made identification easy.
Mutant spinal cord permits ingrowth by wild-type dorsal root ganglia (A; the ectopic wild-type DRG is indicated by the white arrowhead,
and the black arrowhead indicates the projection from the wild-type DRG into the mutant spinal cord). In contrast, wild-type DRG will not
grow into wild-type spinal cord (B; again, the ectopic DRG is indicated by the arrowhead); axons from mutant DRGs also cannot enter
wild-type spinal cord (C; the mutant DRG is indicated by the arrowhead).
FIG. 1. Defects in axon guidance in Noggin mutants. (A, B) Defects in projections of motor axons to the distal part of the forelimbs. Mouse
forelimbs stained with the anti-neurofilament antibody 2H3 and also with Alcian blue (to detect condensing cartilage). (C, D) Defects in
projection of cranial nerve VII, visualized by whole-mount staining with 2H3. Viewed from the anterior–ventral side; anterior is to the top.
In a wild-type animal (C), the anteriormost projection from CN VII projects anteriorly and medially before turning laterally (arrowhead).
In Noggin mutants (D), some axons follow the correct path (arrowhead), while others continue medially across the midline (arrow). (E, F)
Gross defects in dorsal root ganglia, visualized by staining with 2H3. Dorsal views, at the level of the forelimbs; anterior is up. Note the
discrete ganglia present in the wild-type (E), as compared with the mixing of projections between the dorsal root ganglia in the Noggin
mutant (F).
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tants, many of these axons project properly, as can be seen
by the many axons present in the DREZ (Figs. 1F and 2B);
however, a subset of axons project from the DREZ into the
deep spinal cord, passing through the gray matter of the
cord and often reaching the lumen (Figs. 2B and 2D). This
defect was seen in all Noggin mutant animals examined,
and was never present in heterozygotes or wild-type ani-
mals (the wild-type example in Fig. 2A, showing a single
misprojection, is typical; no wild-type section displayed
more than two such misprojections at the level of the
DREZ). The cases shown are typical in only showing this
misprojection on one side of the spinal cord: most sections
showed misprojection only on one side or the other, but
examination of multiple sections from the same animal
revealed that these misprojections were present on both
sides without any clear bias to the right or left, as is evident
from the staining of axons penetrating the spinal cord seen
in Fig. 1F.
Because of these observations, we examined expression of
Noggin in the dorsal spinal cord by staining animals het-
erozygous for the knockout allele for -galactosidase ex-
pression. -Galactosidase antibody staining confirmed pre-
viously observed expression in the roofplate, floorplate, and
notochord and revealed strong expression along the entire
dorsal margin of the spinal cord and low-level expression in
the gray matter of the dorsal spinal cord and the dorsal root
ganglion at e11.5 (Fig. 2C). These observations were con-
firmed by staining for -galactosidase activity (data not
shown).
Because the 2H3 antibody stains all axons, it was not
possible to tell with certainty that the axons present in the
spinal cord gray matter originated in the DRG. Accordingly,
we labeled projections which had reached the limb at e11.5
with DiI. Although most of the labeled axons were from
motor neurons (data not shown), the DRG was labeled as
well and was clearly the origin of the ectopic spinal projec-
tions (Fig. 2E).
Noggin Is Required in the Spinal Cord, Not the
DRG, for Correct Pathfinding
Since Noggin is expressed in both DRG and spinal cord,
we wished to determine whether Noggin protein was re-
quired in the projecting axons, or in the target tissue, for
axon pathfinding. We cultured mutant and wild-type e11.5
dorsal root ganglia adjacent to the ventricular surface of
mutant and wild-type e10.5 spinal cord, sectioned the
explants, stained with the anti-neurofilament antibody
2H3, and scored them for growth into the spinal cord.
Wild-type DRGs grew into mutant spinal cords (4/5) (Fig.
3A); in contrast, wild-type DRGs did not grow into wild-
type spinal cords (1/7; Fig. 3B) and mutant DRGs did not
grow into wild-type spinal cords (0/3; Fig. 3C). These data
localize the requirement for Noggin to the spinal cord.
Dorsal–Ventral Pattern in the Spinal Cord Is
Generally Normal at Forelimb Level
Several groups have reported that dorsal and ventral
spinal cord have differing activities on guidance of DRG
axons in vitro. Ventral spinal cord is strongly repellent in
these assays, while dorsal spinal cord is neutral or weakly
repellent (Keynes et al., 1997; Nakamoto and Shiga, 1998).
We reasoned that our results might reflect dorsalization of
the spinal cord and consequent reduction of repulsion. In
order to test this hypothesis, we examined the expression of
the markers MATH1, MASH1, PAX6, and PAX7 in
forelimb-level mutant and wild-type spinal cord. MATH1,
which marks the most dorsal pool of neural progenitors in
the spinal cord at this stage (Helms and Johnson, 1998), was
mildly expanded (Figs. 4A and 4B, red staining; and data not
shown). MASH1, PAX6, and PAX7, which mark more
ventral pools of neural precursors, were unaffected
(MASH1, green in Figs. 4A and 4B; PAX7, Figs. 4C and 4D;
PAX6, data not shown). We conclude that, although the
dorsalmost fates are mildly expanded, the spinal cord does
not show the global dorsalization which might be expected
to generate the projection defects present in the Noggin
mutant.
In order to further analyze spinal-cord pattern, we assayed
expression of all 17 known mouse Semaphorins (Sema3A–
3C, 3E, 3F, 4A–4D, 4F, 4G, 5A, 5B, 6A–6C, and 7A) in e10.5
and e11.5 forelimb-level spinal cord and DRG by RT-PCR.
Of these, 11 (3A, 3C, 3F, 4A–4D, 4F, 5A, 5B, and 6B) were
expressed at significant levels; none of these were reduced
in Noggin mutant animals (data not shown). We also
examined expression of Ephrin-B1, -B2, and -B3 by in situ
hybridization and immunofluorescence. Ephrin-B1 and
Ephrin-B2 were both expressed in the dorsal spinal cord gray
matter; their expression was unchanged in Noggin mutants,
as was expression of all three Ephrin-B’s as revealed by
immunofluorescence (Figs. 4E–4J). RT-PCR analysis re-
vealed that EphB2, EphB3, and EphB4 are all expressed in
dorsal root ganglia, and are not disrupted in Noggin mutants
(Fig. 4K).
BMPs Fail to Attract or Repel DRG Axons in Vitro
Since we had begun these experiments in part to find
axons which might be guided by BMP signals, we wished to
see whether or not DRG axons would respond to BMP
gradients in vitro. Accordingly, we dissected dorsal root
ganglia from wild-type e11.5 embryos and cultured them as
previously described (Keynes et al., 1997), in combination
with HEK293 cell pellets expressing BMP2, BMP4, BMP7,
or GDF7. We chose these BMPs because BMP2 and BMP4,
and the GDF7-related protein GDF6, interact with Noggin
with high affinity (Chang and Hemmati-Brivanlou, 1999;
Zimmerman et al., 1996), while BMP7 has been shown to
be able to act in guidance of commissural neurons (Augs-
burger et al., 1999). In our hands, BMP2, BMP4, BMP7, and
GDF7-transfected cell pellets had no effect on outgrowth
from cultured DRGs (Figs. 5A–5D). We confirmed that our
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cells produced BMPs by immunoprecipitation followed by
Western blot (data not shown).
In many assays, BMP heterodimers have been shown to
have different signaling properties from homodimers (Aono
et al., 1995; Israel et al., 1996). Noggin is able to block
signaling by heterodimers as well as by homodimers (Eimon
and Harland, 1999). In order to test the chemotactic prop-
erties of BMP heterodimers, we cotransfected cells with
BMP4 and BMP7, BMP7 and GDF7, and BMP4 and GDF7.
None of these combinations were any more effective than
BMP4, BMP7, or GDF7 alone (Figs. 5E and 5F; and data not
shown).
It was also possible that BMPs might not be chemotactic
agents themselves, but might alter the responsiveness of
DRG axons to other chemotactic agents. Accordingly, we
examined the responsiveness of DRG axons to Sema3A and
Sema3F, with and without BMPs. Both of these signals
repelled early DRG axons (Figs. 4G and 4I; and data not
shown). Coexpression of BMP4, BMP7, or GDF7 did not
alter the response to either of these repellents (Figs. 5H and
5J; and data not shown). The response to Slit1 was also
unchanged (data not shown).
DISCUSSION
Noggin Is Required for Proper Axonal Pathfinding
We have presented data which show that Noggin is
required for correct peripheral axonal pathfinding in the
mouse embryo (Figs. 1 and 2). We have chosen to focus on
the altered pathfinding of centrally projecting DRG axons
(Fig. 2). Noggin activity is required in the spinal cord and
not in the DRG axons themselves (Fig. 3). The nature of the
requirement for Noggin remains obscure, although we have
demonstrated that the defects are not simply a result of
altered patterning of the spinal cord (Fig. 4), that BMPs are
not themselves guidance cues for DRG axons (Fig. 5), and
that BMPs are not able to alter the response to other known
cues for DRG axons (Fig. 5). Together, we take these data to
indicate that excess BMP signaling in Noggin mutant mice
disrupts reception of some unknown repulsive cue for DRG
axons.
How Are Axons Excluded from the Ventricular
Zone?
One important aspect of axon guidance is the prevention
of axonal growth into inappropriate areas. Is misprojection
of axons into such regions simply the result of the proper
action of neuron-specific attractants and repellents, or are
there more general axonal repellents expressed in regions
where axons should not grow? Our work suggests that the
repellents in the ventricular zone of the spinal cord are
somewhat specific for different neural types: while the
DRG axons misproject into the ventricular zone, the trajec-
tory of commissural axons (which must skirt the ventricu-
lar axonal–exclusion zone) is apparently unchanged. This
issue has been examined previously in the dorsal root
ganglion: previous authors have concluded that the preven-
tion of axonal entry into the ventricular zone is dependent
on activities of NCAMs, especially Axonin/SC1, Ng-CAM
and Nr-CAM (Shiga et al., 1997). Although our work is
generally compatible with these findings, NCAM is not
expressed in the deep spinal cord at e11.5 (Lustig et al.,
2001), suggesting that there must be other repellents in the
gray matter at these early stages. The expression of
Ephrin-B1 and Ephrin-B2 in the gray matter of the dorsal
spinal cord, and the expression of EphB2, EphB3, and EphB4
in the dorsal root ganglion, suggests that these factors may
play roles in preventing ectopic growth of DRG axons into
the gray matter. We have been unable to demonstrate
repulsion of DRG axons by preclustered Ephrin-B2 in col-
lagen cultures. However, this experimental paradigm may
not accurately reflect the in vivo case. If B-class Ephrins are
repellents for DRG axons in vivo, the clearest explanation
of our data are that BMPs are capable of disrupting EphB
signal transduction.
In this context, it may be notable that those axons which
misproject into the ventricular zone in Noggin mutants
almost invariably adopt the apparent shortest path from the
DREZ to the lumen. This suggests that there may be some
attractant in the ventricular zone, whose effect is normally
masked by the ventricular-zone repulsion; this attraction
would make ventricular-zone repulsion all the more impor-
tant.
Sema3A and Sema3F Are Repellents
for Early-Emerging DRG Axons
In our assays, Sema3F and Sema3A were both repulsive
for early-emerging, NGF-responsive DRG axons. This is in
keeping with previous reports for Sema3A (Messersmith et
al., 1995). The behavior of these axons in response to
Sema3F has not been previously reported; it is intriguing
that Sema3A and Sema3F should act similarly, since previ-
ous work has shown that these signals have different effects
on olfactory bulb neurons and that their effects are likely to
be mediated to some extent by different receptors (de Castro
et al., 1999; Nakamura et al., 2000).
Assays for BMPs as Chemotactic Agents
In our hands, BMPs failed to affect the outgrowth of axons
from dissected dorsal root ganglia in vitro. The most obvi-
ous explanation for this result is that these neurons are
simply unresponsive to BMP signals, in vivo as well as in
vitro. However, an alternative explanation is suggested by
results on homing of immune cells to TGF1 (Adams et al.,
1991; Brandes et al., 1991). TGF1 can act as a chemoat-
tractant for monocytes, lymphocytes, and neutrophils, but
this attraction is abrogated at high concentrations of
TGF1. For example, monocytes are maximally attracted at
a TGF1 concentration of 0.4 fM, an attraction which is
lost at levels of 400 fM; neutrophils are maximally attracted
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at 20 fM, and again, the effect is lost at 400 fM. This effect
is probably due to maximal receptor occupation on all sides
of the cell at high concentrations of ligand. A similar effect
could pertain here. It is notable in this context that previous
studies showing an in vitro effect from BMPs have involved
BMP diffusion through tissue, rather than through collagen
(Augsburger et al., 1999); this may result in a lower local
concentration of BMP protein, or a steeper gradient.
BMPs as Signal Disruptors
Despite the argument above on the possibility that BMP
gradients may be difficult to assay in collagen cultures, we
interpret our results as suggesting that overactive BMP
signals may disrupt responses to some other axon-guidance
cue. It is clear from our data that the pattern of the spinal
cord is essentially normal, and yet in our explant assays, the
FIG. 4. Pattern of the spinal cord is normal in Noggin mutants. (A, B) Expression of MATH-1 (red) and MASH-1 (green) in forelimb-level
spinal cord of wild-type (A) and Noggin-mutant (B) e11.5 mouse embryos. MATH-1 marks the dorsalmost pool of neuronal precursors, and
is mildly expanded; MASH-1 marks a more ventral set of cells, and is apparently unaffected. (C, D) Expression of PAX7 (green) in
forelimb-level spinal cord of wild-type (C) and Noggin-mutant (D) e11.5 mouse embryos. PAX7 shows little or no change in expression.
(E–H) Ephrin-B1 (E, F) and Ephrin-B2 expression (G, H) in forelimb-level spinal cord of wild-type (E, G) and Noggin-mutant (F, H) e11.5
mouse embryos. (I, J) Immunofluorescent localization of total Ephrin-B protein in forelimb-level spinal cord and dorsal root ganglion of
wild-type (I) and Noggin-mutant (J) mouse embryos. Again, there is no apparent change in localization. Note the Ephrin-B expression
completely surrounding the DREZ and DRG. (K) Expression of Eph-B2, Eph-B3, and Eph-B4 in dorsal root ganglia dissected from
Noggin-mutant and wild-type mouse embryos. Odc is Ornithine Decarboxylase, a loading control. In each case, the first lane is the
RT-PCR, and the second is a reaction carried out without reverse transcriptase, as a control against contamination with genomic DNA.
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defect localized to the spinal cord; this suggests that the
signal being affected must be more or differently sensitive
to BMP signals than is overall spinal cord pattern. This
leaves two possibilities: either the expression of some
guidance molecule is significantly disrupted in the absence
of other detectable fate defects, or BMP signals can directly
disrupt reception of some other axonal chemorepellent.
The first possibility cannot be absolutely excluded on the
basis of our data, but seems unlikely based on the large
number of spinal cord markers examined. The second
possibility, that BMPs must be blocked to present direct
disruption of other signals, emerges as a more plausible
explanation.
There are many examples of this kind of signal competi-
tion in the literature. The best-studied cases involve disrup-
tion of TGF class signals by EGF or HGF, in which cases,
MAP kinase activation or Ras activation prevent BMP/
TGF responsiveness (Kretzschmar et al., 1997, 1999).
Conversely, TGF is able to block proliferation in response
to EGF in many cell lines (Like and Massague, 1986). To our
knowledge, this kind of effect has not previously been
demonstrated to be important in development.
This point raises an interesting subtlety in the biological
action of BMP antagonists. It has often been asserted that
the role of BMP antagonism in various biological processes
is simply to prevent BMP signals from being received and
hence to permit tissues to follow “default” pathways of
differentiation (Hemmati-Brivanlou and Melton, 1997).
However, our data suggest that the role of BMP antagonism
may be not only to simply block BMP signals but also to
permit the activity of other signals which would otherwise
be directly suppressed by BMP signal activation.
FIG. 5. BMPs cannot guide DRG axons or change responses to Semaphorin 3A or 3F in vitro. (A–F) DRG axons do not obviously respond
to BMP homodimers or heterodimers. GFP-transfected 293 cells (A) were not significantly attractive or repulsive for DRG axons in collagen
cultures; the same was true of cells expressing BMP4 (B), BMP7 (C), GDF7 (D), BMP4 and BMP7 (E), or GDF7 and BMP7 (F). (G–J) Sema3A
(G) and Sema3F (I) both repel DRG axons; BMP4 does not alter the response to Sema3A (H), and BMP7 does not alter the response to Sema3F
(J). (I) and (J) show two DRGs with each pellet to show an effect which was persistent with the semaphorins: the semaphorins were
persistently more efficient at preventing growth in the anterior–posterior direction relative to the DRG axis than in the dorsal–ventral
direction (in each case, the left-hand DRG is oriented with the AP axis pointing toward the pellet, and the right-hand explant is orthogonal
to this, within the plane of the paper.) Each of these experiments was performed at least nine times, with consistent results.
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